tiprankstipranks
Trending News
More News >

Shandong Xinhua Pharmaceutical Gains Approval for Ibuprofen Suspension Drops

Story Highlights
Shandong Xinhua Pharmaceutical Gains Approval for Ibuprofen Suspension Drops

Confident Investing Starts Here:

The latest update is out from Shandong Xinhua Pharmaceutical Company Limited Class H ( (HK:0719) ).

Shandong Xinhua Pharmaceutical Company Limited has announced the receipt of a Drug Registration Certificate for its Ibuprofen Suspension Drops from the National Medical Products Administration. This approval allows the product to be marketed as an over-the-counter drug, potentially enhancing the company’s market presence in the pharmaceutical industry.

More about Shandong Xinhua Pharmaceutical Company Limited Class H

Shandong Xinhua Pharmaceutical Company Limited is a pharmaceutical company based in China, primarily engaged in the production and sale of pharmaceutical products. The company focuses on the development and distribution of over-the-counter drugs, with a particular emphasis on chemical pharmaceuticals.

Average Trading Volume: 4,104,058

Technical Sentiment Signal: Strong Buy

Current Market Cap: HK$9.7B

For a thorough assessment of 0719 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App